Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NEUPNEUP
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NEUPHORIA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 72,559 shares of NEUP (NEUPHORIA THERAPEUTICS INC), worth $317,083 as of 2026-Q2. The position was increased (+275.4% shares).

Current Value

$317,083

Current Shares

72,559

Total Value Change

+$213,380

Total Shares Change

+57,953

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
72,559
+275.4%
$317,0830.0%$4.37
26
2026-Q1
New
19,331
-
$78,6770.0%$4.35
33
2025-Q3
Exited
0
-100.0%
$00.0%$11.86
0
2025-Q2
New
14,606
-
$103,7030.0%$7.00
33

Other major holders of NEUP: VANGUARD CAPITAL MANAGEMENT LLC, BALYASNY ASSET MANAGEMENT L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used